Persian News

Actoverco Pharmaceutical Company

Selected Persian News

4R4A5641-1-2048x1365

Actover Pharmaceutical Group Participates in the 10th IRAN PHARMA Exhibition

28 September 2025
4R4A3136-2048x1365 (1)

Actoverco Medical Director Stated: A Strong Commitment to the “Pharmacovigilance” System Ensures the Safety and Reliability of Actover Products

28 September 2025
M_HA18361-2048x1365

Actover Group Unveils “Zeponim” for the Management of Multiple Sclerosis and Ulcerative Colitis

11 August 2025
nexus23

Nexus CEO Calls for Equal Market Opportunities for Domestic Supplements at Iran Supplex 2025

29 July 2025
4R4A0525

Actover Pharmaceutical Group Showcases Its Neurology Portfolio at the 32nd Iranian Congress of Neurology and Clinical Electrophysiology

6 May 2025

Production of more the 600 thousands of Remdesivir vials

4 January 2021 | Author: Actoverco

“Currently, about 6 million people in the country are constantly taking various drugs of Actoverco” said the director of the Actoverco’s factory.